Last reviewed · How we verify

NCT05724667

An Evaluation of a Flippin' Pain Seminar Series

Completed Last updated 13 February 2023
What this trial tests

trial testing Flippin' Pain Seminar Series in Chronic Pain in 442 participants. Completed in 1 April 2022.

Timeline
15 February 2022
Primary endpoint
23 March 2022
1 April 2022

Quick facts

Lead sponsorTeesside University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment442
Start date15 February 2022
Primary completion23 March 2022
Estimated completion1 April 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Teesside University

Who can join

16 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to evaluate a chronic pain seminar series, Flippin' Pain. The primary aim is to examine the impact of the seminars on attendees' beliefs and perceptions of the following with regards to chronic pain: medications, surgery, physical activity, and scans. A secondary aim is to examine attendees' experience of the seminar events. Seminar attendees included people with chronic pain and on an NHS waiting list for treatment, people with chronic pain and not on an NHS waiting list for treatment, healthcare professionals and non-healthcare professionals without chronic pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Teesside University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05724667.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing